Through an analysis of the transcriptome data of patients from TCGA with 33 kinds of cancers, we found the distinct expression patterns of NXPH4 across multiple cancers and specifically explored its clinical relevance in bladder cancer. The gene discussed is NXPH4; the disease is urinary bladder carcinoma.